SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001193125-24-141798
Filing Date
2024-05-17
Accepted
2024-05-17 16:36:00
Documents
10
Period of Report
2024-05-17

Document Format Files

Seq Description Document Type Size
1 PREM14A d787069dprem14a.htm PREM14A 2712265
2 EX-FILING FEES d787069dexfilingfees.htm EX-FILING FEES 17063
3 GRAPHIC g787069dsp161.jpg GRAPHIC 217641
4 GRAPHIC g787069dsp162.jpg GRAPHIC 123857
5 GRAPHIC g787069g00k05.jpg GRAPHIC 88195
6 GRAPHIC g787069g14w57.jpg GRAPHIC 62234
7 GRAPHIC g787069g40u42.jpg GRAPHIC 20037
8 GRAPHIC g787069g65m78.jpg GRAPHIC 64312
9 GRAPHIC g787069g67b93.jpg GRAPHIC 38130
10 GRAPHIC g787069g93f08.jpg GRAPHIC 46409
  Complete submission text file 0001193125-24-141798.txt   3610511
Mailing Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808
Business Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808 877-354-3689
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-40708 | Film No.: 24960453
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)